to-BBB presents clinical data on lead product 2B3-101, a potential new treatment option for patients with brain cancer an active transport processes at the blood-brain barrier.
Thu, 26/09/2013 - 09:16
Tue, 10/09/2013 - 09:59
Cambridge Research Biochemicals (CRB), a British company specialising in custom supply of research reagents, principally peptides and antibodies for medical research and the Pharmaceutical industry, today announced that i
Mon, 02/09/2013 - 09:15
University of Warwick wins Domainex’s first Discovery STAR Award to Support hunt for new Chagas Disease Treatment